CDC addresses burden, threat of antibiotic resistance

CDC addresses burden, threat of antibiotic resistance
The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Noting that is a worldwide problem, researchers from the CDC discuss the burden and threat of antibiotic resistance to bacteria that can cause severe human infections.

The researchers note that antibiotic resistance causes an estimated minimum of two million illnesses and 23,000 deaths per year, and one of the most urgent threats is Clostridium difficile, which causes an estimated minimum of 250,000 illnesses and 14,000 deaths per year. The estimated costs of antibiotic resistance could be as high as $20 billion in direct costs and $35 billion in indirect costs such as lost productivity. Antibiotic use is the most important factor leading to antibiotic resistance, with up to 50 percent of antibiotics prescribed inappropriately. The spread of resistant strains from person to person or from non-human sources is also a major factor in antibiotic resistance. The four core actions to combat antibiotic-resistant infection are prevention of infections and of the spread of resistance; tracing resistant bacteria; improving antibiotic use; and promoting the development of .

"When first-line and then second-line antibiotic treatment options are limited by resistance or are unavailable, are forced to use antibiotics that may be more toxic to the patient and frequently more expensive and less effective," CDC Director Tom Frieden, M.D., M.P.H., said in a statement.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

CDC sounds alarm on antibiotic-resistant bacteria

Sep 16, 2013

(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday ...

Global effort is needed to keep antibiotics working

Nov 19, 2013

A global approach is needed to address the unfolding burden of antibiotic resistance, say the authors of a new report, published this week in Lancet Infectious Diseases. The report coincides with the Europe ...

Antibiotics – friend and foe?

Nov 18, 2013

European Antibiotic Awareness Day is marked on the 18th November every year. This year in Norway, a seminar for health care providers about antibiotic use and resistance will be held, as well as several local events around ...

3Qs: The effect of antibiotic resistant bacteria

Oct 02, 2013

Last month, the Centers for Disease Control and Prevention released a report titled Antibiotic resistance threats in the United States, 2013, that served as a first-ever snapshot of the effect antibiotic ...

Recommended for you

Recorded Ebola deaths top 7,000

7 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

11 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.